» Articles » PMID: 19710909

Glyoxalase I Gene Deletion Mutants of Leishmania Donovani Exhibit Reduced Methylglyoxal Detoxification

Overview
Journal PLoS One
Date 2009 Aug 28
PMID 19710909
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Glyoxalase I is a metalloenzyme of the glyoxalase pathway that plays a central role in eliminating the toxic metabolite methyglyoxal. The protozoan parasite Leishmania donovani possesses a unique trypanothione dependent glyoxalase system.

Principal Findings: Analysis of the L. donovani GLOI sequence predicted a mitochondrial targeting sequence, suggesting that the enzyme is likely to be targeted to the mitochondria. In order to determine definitively the intracellular localization of GLOI in L. donovani, a full-length GLOI gene was fused to green fluorescent protein (GFP) gene to generate a chimeric construct. Confocal microscopy of L. donovani promastigotes carrying this chimeric construct and immunofluorescence microscopy using anti-GLOI antibodies demonstrated that GLOI is localized in the kinetoplast of the parasite apart from the cytosol. To study the physiological role of GLOI in Leishmania, we first created promastigote mutants heterozygous for GLOI by targeted gene replacement using either hygromycin or neomycin phosphotransferases as selectable markers. Heterozygous mutants of L. donovani display a slower growth rate, have lower glyoxalase I activity and have reduced ability to detoxify methylglyoxal in comparison to the wild-type parasites. Complementation of the heterozygous mutant with an episomal GLOI construct showed the restoration of heterozygous mutant phenotype nearly fully to that of the wild-type. Null mutants were obtained only after GLOI was expressed from an episome in heterozygous mutants.

Conclusions: We for the first time report localization of GLOI in L. donovani in the kinetoplast. To study the physiological role of GLOI in Leishmania, we have generated GLOI attenuated strains by targeted gene replacement and report that GLOI is likely to be an important gene since GLOI mutants in L. donovani showed altered phenotype. The present data supports that the GLOI plays an essential role in the survival of this pathogenic organism and that inhibition of the enzyme potentiates the toxicity of methylglyoxal.

Citing Articles

Metatranscriptomes-based sequence similarity networks uncover genetic signatures within parasitic freshwater microbial eukaryotes.

Monjot A, Rousseau J, Bittner L, Lepere C Microbiome. 2025; 13(1):43.

PMID: 39915863 PMC: 11800578. DOI: 10.1186/s40168-024-02027-0.


Multiscale Process Modelling in Translational Systems Biology of Leishmania major: A Holistic view.

Chauhan N, Singh S Sci Rep. 2020; 10(1):785.

PMID: 31964958 PMC: 6972910. DOI: 10.1038/s41598-020-57640-4.


Integrative Computational Framework for Understanding Metabolic Modulation in Leishmania.

Chauhan N, Singh S Front Bioeng Biotechnol. 2019; 7:336.

PMID: 31803732 PMC: 6877600. DOI: 10.3389/fbioe.2019.00336.


Characteristic Variations and Similarities in Biochemical, Molecular, and Functional Properties of Glyoxalases across Prokaryotes and Eukaryotes.

Kaur C, Sharma S, Hasan M, Pareek A, Singla-Pareek S, Sopory S Int J Mol Sci. 2017; 18(4).

PMID: 28358304 PMC: 5412262. DOI: 10.3390/ijms18040250.


Lactoylglutathione lyase, a critical enzyme in methylglyoxal detoxification, contributes to survival of Salmonella in the nutrient rich environment.

Chakraborty S, Gogoi M, Chakravortty D Virulence. 2014; 6(1):50-65.

PMID: 25517857 PMC: 4603430. DOI: 10.4161/21505594.2014.983791.


References
1.
Clugston S, BARNARD J, Kinach R, Miedema D, Ruman R, Daub E . Overproduction and characterization of a dimeric non-zinc glyoxalase I from Escherichia coli: evidence for optimal activation by nickel ions. Biochemistry. 1998; 37(24):8754-63. DOI: 10.1021/bi972791w. View

2.
Gillespie E . The tumor promoting phorbol diester, 12-O-tetradecanoylphorbol-13-acetate (TPA) increases glyoxalase I and decreases glyoxalase II activity in human polymorphonuclear leukocytes. Biochem Biophys Res Commun. 1981; 98(2):463-70. DOI: 10.1016/0006-291x(81)90862-7. View

3.
Padmanabhan P, Mukherjee A, Singh S, Chattopadhyaya S, Gowri V, Myler P . Glyoxalase I from Leishmania donovani: a potential target for anti-parasite drug. Biochem Biophys Res Commun. 2005; 337(4):1237-48. DOI: 10.1016/j.bbrc.2005.09.179. View

4.
Bello A, Nare B, Freedman D, Hardy L, Beverley S . PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major. Proc Natl Acad Sci U S A. 1994; 91(24):11442-6. PMC: 45247. DOI: 10.1073/pnas.91.24.11442. View

5.
Brandau S, DRESEL A, Clos J . High constitutive levels of heat-shock proteins in human-pathogenic parasites of the genus Leishmania. Biochem J. 1995; 310 ( Pt 1):225-32. PMC: 1135877. DOI: 10.1042/bj3100225. View